Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
2
×
national top stories
new york
new york blog main
new york top stories
abbvie
acorda therapeutics
akcea therapeutics
ampyra
anylam pharmaceuticals
apokyn
apomorphine
cardiomyopathy
dalfampridine
drugs
duopa
inbrija
inotersen
mylan
neuropathy
onpattro
parkinson's disease
patisiran
paul matteis
pfizer
san diego blog main
san diego top stories
stiel
sunovion pharmaceuticals
tafamidis
tegsedi
transthyretin amyloidosis
What
approved
disease
2
×
drug
2
×
fda
patients
2
×
acorda
ago
akcea
alnylam
amyloidosis
attr
available
battle
cope
debilitating
episodes
friday
genetic
gets
help
late
looms
meant
medications
medicines
new
nod
oks
parkinson’s
pfizer
rare
rival
sets
stop
transthyretin
treatment
working
year
Language
Current search:
disease
×
drug
×
" national blog main "
×
patients
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms